应用梅毒螺旋体转录介导扩增试验及时诊断潜伏期梅毒感染
在荷兰阿姆斯特丹性健康中心,2021年9月至2022年8月期间,对国家暴露前预防(PrEP)项目参与者的9974次就诊样本加做梅毒螺旋体转录介导扩增试验(TP-TMA)。191例传染性梅毒中,79例(41%)至少1份样本TP-TMA阳性;16例TP-TMA阳性与常规诊断不一致,其中5例在随访就诊时确诊梅毒。加做TP-TMA额外发现14/191(7%)梅毒感染。
要点
- 在PrEP项目参与者中,加做TP-TMA可额外发现7%(14/191)的梅毒感染。
- 191例传染性梅毒中41%(79例)至少1份样本TP-TMA阳性。
- 16例TP-TMA阳性与常规诊断不一致,其中5例在随访就诊时确诊梅毒。
核心结论
- 将TP-TMA试验加入常规诊断后,在国家PrEP项目参与者中额外发现14/191(7%)的梅毒感染。
- TP-TMA试验是有用的诊断工具,可提高梅毒病例发现,从而限制梅毒传播。
研究设计与样本
- 研究纳入2021年9月至2022年8月期间在阿姆斯特丹性健康中心(SHC)就诊的所有国家暴露前预防(PrEP)项目参与者。
- 共纳入3283名参与者的9974次SHC就诊。
- 为筛查沙眼衣原体和淋病奈瑟菌采集的肛门、咽、阴道和尿液样本,额外用基于检测TP 23S rRNA的TP-TMA试验检测。
主要发现
- 共诊断191例传染性梅毒:26例(14%)一期梅毒,54例(29%)二期梅毒,111例(58%)早期潜伏梅毒。
- 191例梅毒中79例(41%)至少1份样本TP-TMA阳性。
- 16名参与者的TP-TMA阳性结果与常规诊断不一致:其中2人在就诊前一周内因梅毒接受治疗,8人在就诊时因梅毒通知或另一种性传播感染接受治疗,5人在随访就诊时确诊梅毒,1人失访。
关键数值与推荐
- TP-TMA试验基于检测梅毒螺旋体(TP)的23S rRNA。
- 常规诊断包括为筛查沙眼衣原体和淋病奈瑟菌采集的肛门、咽、阴道和尿液样本。
临床怎么用
- 作者认为,TP-TMA试验是有用的诊断工具,可提高梅毒病例发现,从而限制梅毒传播。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Syphilis is a complex, multistage, sexually transmitted infection (STI) caused by the bacterium Treponema pallidum subspecies pallidum (TP). New diagnostic tools are needed to minimize transmission. In this study, we aimed to assess the additional value of an investigational transcription-mediated amplification test for TP (TP-TMA) for routine diagnostics. METHODS: Between September 2021 and August 2022, visits by all participants of the national preexposure prophylaxis (PrEP) program at the sexual health center (SHC) in Amsterdam were included. Anal, pharyngeal, vaginal, and urine samples collected for Chlamydia trachomatis and Neisseria gonorrhoeae screening were additionally tested with the TP-TMA assay based on detection of 23S rRNA of TP. RESULTS: In total, 9974 SHC visits by 3283 participants were included. There were 191 infectious syphilis cases diagnosed: 26 (14%) primary syphilis, 54 (29%) secondary syphilis, and 111 (58%) early latent syphilis. In 79 of the 191 (41%) syphilis cases, at least 1 sample was TP-TMA-positive. For 16 participants, the positive TP-TMA result was not concordant with routine diagnostics. Of those, 2 participants were treated for syphilis within a week before the visit. Eight participants were treated for a syphilis notification at the visit or for another STI. Five participants were diagnosed with syphilis at the following visit, and 1 participant was lost to follow-up. CONCLUSIONS: By adding the TP-TMA assay to routine diagnostics, we identified 14 of 191 (7%) additional syphilis infections among participants of the national PrEP program. The TP-TMA assay is a useful diagnostic tool to increase syphilis case finding and thus limit the transmission of syphilis.
引用
- Zondag HCA, van Dam AP, Bosch J, et al. Timely Diagnosis of Incubating Syphilis Infections Using Treponema pallidum Transcription-Mediated Amplification Assay. Clin Infect Dis. 2023. PMID: 37536265. doi:10.1093/cid/ciad455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。